EFPIA, EBE and EuropaBio welcome European Commission Consensus Information Document on biosimilars in the European pharmaceutical environment

The European Federation of Pharmaceutical Industries & Associations (EFPIA), its specialised group the European Biopharmaceutical Enterprises (EBE) and the European Association for Bioindustries (EuropaBio) welcome the consensus information document on biosimilars that was approved by the European Commission Steering Group on Access to Medicines in Europe on 17th April. The Commission will present the document at the BIO international Convention in Chicago on 23rd April. The document discusses the specifics around biosimilar medicinal products, the requirements for their marketing authorization in the EU, their market performance, and the necessary conditions within the EU pharmaceutical market to ensure there is informed and adequate use of these medicines.
Download | pdf 420.97 kB